The induction of nitric oxide by interleukin-12 and tumor necrosis factor-α in human natural killer cells: Relationship with the regulation of lytic activity

Blood

Volumn 92, Issue 6, 1998, Pages 2093-2102

  Salvucci, Ombretta ^a   Kolb, Jean Pierre ^a   Dugas, Bernard ^a   Dugas, Nathalie ^a   Chouaib, Salem ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; CYTOLYSIN; FAS LIGAND; GRANZYME A; INTERLEUKIN 12; NITRIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STIMULATION; CYTOLYSIS; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOSTIMULATION; IMMUNOSURVEILLANCE; LYMPHOKINE ACTIVATED KILLER CELL; NATURAL KILLER CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; VIRUS INFECTION;

EID: 0032530352     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.6.2093     Document Type: Article

References (53)

1. Trinchieri G: Biology of natural killer. Adv Immunol 47:187, 1989
2. Robertson MJ, Ritz J: Biology and clinical relevance of human natural killer cells. Blood 76:2421, 1990
3. Henney CS. Kuribayashi K, Kern DE, Gillis S: Interleukin 2 augments natural killer cell activity. Nature 291:335, 1981
4. Trinchieri G, Matsumoto-Kobayashi M, Clark SC, Sheehra J, London L, Perussia B: Response of resting human peripheral blood natural killer cells to interleukin-2. J Exp Med 160:1147, 1984
5. Ellis TM, McKenzie RS, Simms PE, Helfrich BA, Fisher RI: Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma. J Immunol 143:4282, 1989
6. Robinet E, Kamoun M, Farace F, Chouaib S: Interleukin-4 differentially regulates interleukin-2-mediated and CD2-mediated induction of human lymphokine-activated killer effectors. Eur J Immunol 22:2861, 1992
7. Chouaib S, Bertoglio J, Blay JY, Marchiol-Fournigault C, Fradelizi D: Lymphokine activated killers generation pathways: Synergism between tumor necrosis factor and interleukin-2. Proc Natl Acad Sci USA 85:6875, 1988
8. Salvucci O, Mami-Chouaib F, Moreau JL, Thèze J, Chehimi J, Chouaib S: Differential regulation of interleukin-12 and interleukin-15-induced natural killer cell activation by interleukin-4. Eur J Immunol 26:2736, 1996
9. Young JDE, Hengartener H, Podack ER, Cohn ZA: Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity. Cell 44:849, 1986
10. Clark WR: Perforin-a primary or auxiliary lytic mechanism? Immunol Today 9:101, 1988
11. Clement MV, Haddad P, Soulie A, Legros-Maida S, Guillet J, Cesar E, Sasportes M: Involvement of granzyme B and perforin gene expression in the lytic potential of human natural killer cells. Res Immunol 141:477, 1990
12. Henkart PA: Lymphocyte-mediated cytotoxicity: Two pathways and multiple effector molecules. Immunity 1:343, 1994
13. Berke G: The CTL's kiss of death. Cell 81:9, 1995
14. Arase H, Arase N, Saito T: Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med 181:1235, 1995
15. Juretic A, Spagnoli GC, Von Bremen K, Hörig H, Filgueira L, Lüscher U, Babst R, Harder F, Heberer M: Generation of lymphokine-activated killer activity in rodents but not in humans is nitric oxide dependent. Cell Immunol 157:462, 1994
16. Cifone MG, Festuccia C, Cironi L, Cavallo G, Chessa MA, Pensa V, Tubaro E, Santoni A: Induction of the nitric oxide-synthesizing pathway in fresh and Interleukin 2-cultured rat natural killer cells. Cell Immunol 157:181, 1994
17. Filep JG, Baron C, Lachance S, Perreault C, Chan JS: Involvement of nitric oxide in target-cell lysis and DNA induced by murine natural killer cells. Blood 87:5136, 1996
18. Nathan C: Nitric oxide as secretory product of mammalian cells. FASEB J 6:3051, 1992
19. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109, 1991
20. Dugas B, Debré P, Moncada S: Nitric oxide a vital poison inside the immune and inflammatory network. Res Immunol 146:664, 1996
21. Moncada S, Higgs EA: Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 9:1319, 1995
22. Nathan CF, Hibbs JB: Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 3:65, 1991
23. Nussler AK, Billiar TR: Inflammation, immunoregulation and inducible nitric oxid synthase. J Leukoc Biol 54:171, 1993
24. Palmer RMJ, Ferrige AS, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524, 1987
25. Knowles RG, Moncada S: Nitric oxide synthases in mammals. Biochem J 298:249, 1994
26. Nathan C, Xie QW: Nitric oxide synthases: Roles, tolls, and controls. Cell 78:915, 1994
27. Sotomayor EM, DiNapoli MR, Calderon C, Colsky A, Fu Y-X, Lopez DM: Decreased macrophage-mediated cytotoxicity in mammary-tumor-bearing mice is related to an alteration of nitric oxide production and/or release. Int J Cancer 60:660, 1995
28. Misko TP,Moore WM. Kasten TP, Nickols GA, Corbett JA, Tilton RG, McDaniel ML, Williamson JR, Currie MG: Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 233:119, 1993
29. Garvey EP, Oplinger JA, Tanoury GJ, Sherman PA, Fowler M, Marshall S, Harmon MF, Paith JE, Furfine ES: Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas. J Biol Chem 269:26669, 1994
30. Hamid Q, Springall DR, Riveros-Moreno V, Chanez P, Howarth P, Redington A, Bousquet J, Godard P, Holgate S, Polak JM: Induction of nitric oxide synthase in asthma. Lancet 342:1510, 1993
31. Miossec C, Faure F, Ferradini L, Roman-Roman S, Jitsukawa S, Ferrini S, Moretta A, Triebel F, Hercend T: Further analysis of the T cell receptor gamma/delta+ peripheral lymphocyte subset: The Vdeltal gene segment is expressed with either Calpha or Cdelta. J Exp Med 171:1171, 1990
32. Paul-Eugène N, Mossalayi MD, Sarfati M, Yamaoka K, Aubry JP, Bonnefoy JY, Dugas B, Kolb JP: Evidence for a role of Fc∈RII/ CD23 in the IL-4-induced nitric oxide production by normal human mononuclear phagocytes. Cell Immunol 163:314, 1995
33. Chomczynsky P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol- chloroform extraction. Anal Biochem 162:156, 1987
34. Vouldoukis I, Riveros-Moreno V, Dugas B, Ouaaz F, Bécherel P, Debré P, Moncada S, Mossalayi MD: The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc∈RII/CD23 surface antigen. Proc Natl Acad Sci USA 92:7804, 1995
35. Reiling N, Ulmer AJ, Duchrow M, Ernst M, Flad HD, Hauschildt S: Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur J Immunol 24:1941, 1994
36. Riveros-Moreno V, Beddell C, Moncada S: Nitric oxide synthase. Structural studies using anti-peptides antibodies. Eur J Biochem 215:801, 1993
37. Naume B, Johnsen A-C, Espevik T, Sundan A: Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56+ natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12. Eur J Immunol 23:1831, 1993
38. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospísil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G: Induction of interferon γ production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers. J Exp Med 173:869, 1991
39. Krähenbúhl O, Rey C, Jenne D, Lanzavecchia A, Grossurth P, Carrel S, Tschopp J: Characterization of granzymes A and B isolated from granules of cloned human cytotoxic T lymphocytes. J Immunol 141:3471, 1988
40. Clement MV, Haddad P, Soulie A, Legros-Maida S, Guillet J, Cesar E, Sasportes M: Involvement of granzyme B and perforin gene expression in the lytic potential of human natural killer cells. Res Immunol 141:477, 1990
41. Robertson MJ, Soiffer RJ, Wolf SF, Manley TJ, Donahue C, Young D, Herrmann SH, Ritz J: Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): Cytolitic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med 175:779, 1992
42. Denis M: Human monocytes/macrophages: NO or NO? J Leukoc Biol 55:682, 1994
43. Albina JE: On the expression of nitric oxide synthase hy human macrophages. Why no NO? J Leukoc Biol 58:643, 1995
44. Dugas B, Mossalayi MD, Damais S, Kolb JP: Nitric oxide production by human monocytes: Evidence for a role of CD23. Immunol Today 16:574, 1995
45. Hibbs JB, Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranowski RL, Ward JH, Menlove RL, McMurry MP, Kushner JP, Samlowski WE: Evidence for cytokine-inducible nitric oxide from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 89:867, 1992
46. Ochoa JB, Curti B, Peitzman AB, Simmons RL, Billiar TR, Hoffman R, Rault R, Longo DL, Urba WJ, Ochoa AC: Increased circulating nitrogen oxides after human tumor immunotherapy: Correlation with toxic hemodynamic changes. J Natl Cancer Inst 84:864, 1992
47. Huang FP, Feng GJ, Lindop G, DI, Liew FY: The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. J Exp Med 183:1447, 1996
48. Ju DW, Cao X, Acres B: Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma model. Cancer Gene Ther 4:139, 1997
49. Garside P, Hutton AK, Severn A, Liew FY, Mowat AM: Nitric oxide mediates intestinal pathology in graft-vs.- host disease. Eur J Immunol 22:2141, 1992
50. Mule JJ, Krosnick JA, Rosenberg SA: rIL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the rIL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors. J Immunol 142:726, 1989
51. Blay JY, Branellec D, Robinet E, Dugas B, Gay F, Chouaib S: Involvement of cyclic adenosine monophosphate in the interfeukin 4 inhibitory effect on interleukin-2 induced lymphokine-activated killer generation. J Clin Invest 85:1909, 1990
52. Young HA: Regulation of IFN-γ gene transcription. Semin Virol 6:175, 1995
53. Peng HB, Libby P, Liao JK: Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem 270:14214, 1995